Search bioRxiv⌕ Search

bioRxiv · 10.1101/468355

Sketching Algorithms for Genomic Data Analysis and Querying in a Secure Enclave

Abstract

Current practices in collaborative genomic data analysis (e.g. PCAWG [1]) necessitate all involved parties to exchange individual patient data and perform all analysis locally, or use a trusted server for maintaining all data to perform analysis in a single site (e.g. the Cancer Genome Collaboratory). Since both approaches involve sharing genomic sequence data - which is typically not feasible due to privacy issues, collaborative data analysis remains to be a rarity in genomic medicine.\n\nIn order to facilitate efficient and effective collaborative or remote genomic computation we introduce SkSES (Sketching algorithms for Secure Enclave based genomic data analysiS), a computational framework for performing data analysis and querying on multiple, individually encrypted genomes from several institutions in an untrusted cloud environment. Unlike other techniques for secure/privacy preserving genomic data analysis, which typically rely on sophisticated cryptographic techniques with prohibitively large computational overheads, SkSES utilizes the secure enclaves supported by current generation microprocessor architectures such as Intels SGX. The key conceptual contribution of SkSES is its use of sketching data structures that can fit in the limited memory available in a secure enclave.\n\nWhile streaming/sketching algorithms have been developed for many applications in computer science, their feasibility in genomics has remained largely unexplored. On the other hand, even though privacy and security issues are becoming critical in genomic medicine, available cryptographic techniques based on, e.g. homomorphic encryption or garbled circuits, fail to address the performance demands of this rapidly growing field. The alternative offered by Intels SGX, a combination of hardware and software solutions for secure data analysis, is severely limited by the relatively small size of a secure enclave, a private region of the memory protected from other processes. SkSES addresses this limitation through the use of sketching data structures to support efficient secure and privacy preserving SNP analysis across individually encrypted VCF files from multiple institutions. In particular SkSES provides the users the ability to query for the \"k most significant SNPs\" among any set of user specified SNPs and any value of k - even when the total number of SNPs to be maintained is far beyond the memory capacity of the secure enclave.\n\nResultsWe tested SkSES on the complete iDASH-2017 competition data set comprised of 1000 case and 1000 control samples related to an unknown phenotype. SkSES was able to identify the top SNPs with respect to the{chi} 2 statistic, among any user specified subset of SNPs across this data set of 2000 individually encrypted complete human genomes quickly and accurately - demonstrating the feasibility of secure and privacy preserving computation for genomic medicine via Intels SGX.\n\nAvailabilityhttps://github.com/ndokmai/sgx-genome-variants-search

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Kockan, C., Zhu, K., Dokmai, N., Karpov, N., Kulekci, O., Woodruff, D., Sahinalp, C.. 2018-11-12. Sketching Algorithms for Genomic Data Analysis and Querying in a Secure Enclave. https://doi.org/10.1101/468355

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Accelerating discovery and integration from RNA to Protein with R2T2P

Integrating transcriptomics and proteomics data remains an unmet challenge in the post-genomics era, discouraging researchers from pursuing integrative approaches to molecular biology research. Leveraging the power of translation profiling, we present RNA to Translation to Protein (R2T2P), a computational platform integrating genome-guided transcriptome assembly with identification of translation and proteins, including a tailored differential analysis framework and support for multiple reference transcriptomes. We applied R2T2P to investigate a cellular model of facioscapulohumeral muscular dystrophy (FSHD), where ectopic expression of the DUX4 retrogene in skeletal muscle triggers significant alterations in transcription and RNA metabolism. We uncovered hundreds of uncharacterized, highly overexpressed RNAs, including antisense and alternative transcripts, and quantified their contribution to translatome and proteome. Re-analysis of expression datasets from patient-derived myotubes and muscle biopsies validated this alternative transcriptome in FSHD patients, adding a reservoir of bona-fide novel molecular actors in a rare disease. Available at https://github.com/nfdata-omics/R2T2P/, R2T2P is a flexible and powerful workflow in modern integrative biology.

bioinformatics↗

MorphoANOVA: Dissecting Histology-Gene Expression Relationships in Spatial Transcriptomics

Spatial transcriptomics (ST) measures the expression of hundreds to thousands of genes within tissue architecture, often accompanied by histology images. However, it remains challenging to systematically characterize which genes exhibit associations with tissue morphology, whether these associations vary spatially, and which genes show additional spatial expression patterns beyond those captured by morphology. Here we introduce MorphoANOVA, a gene-wise statistical framework for characterizing morphology--expression relationships across genes measured by ST. Using nested spatially varying coefficient models and sequential ANOVA, MorphoANOVA assesses slide-wide associations with an H\&E-derived morphology feature, location-specific changes in these associations, and additional spatial variation after accounting for the selected feature. The resulting statistics enable gene prioritization and pathway enrichment analysis, while spatial component maps support the interpretation of individual genes. Simulations demonstrate MorphoANOVA's ability to distinguish the modeled components and recover their spatial patterns. Applications to human cortex and breast cancer identify biological programs associated with different morphology--expression patterns and reveal distinct relationships with cell composition. Across three HER2-positive breast cancer patients, invasive-cancer marker genes consistently exhibit stronger evidence of location-specific morphology associations. MorphoANOVA thus provides a framework for systematically interpreting spatial gene-expression patterns in relation to tissue morphology.

bioinformatics↗

Evaluation effects can rival reported concordance gains in cross-cancer survival prediction

Studies of cross-cancer learning for survival prediction from tumour omics have reported concordance gains of 0.020 and 0.045, but how such gains compare with evaluation effects remains unclear. We examined these effects across 13 TCGA cancers (5,761 patients, 1,526 disease-specific deaths), using five repeats of five-fold cross-validation and paired bootstrap intervals. When model selection did not use test data, our borrowing model gained 0.009 (95% interval 0.001 to 0.016) over its target-fitted reference when cancers received equal weight (post hoc). Random-effects pooling gave a gain of 0.002 (-0.002 to 0.006), with most weight assigned to cancers where the model made little use of the pretrained score. Choosing the fusion weight on test splits raised the apparent equal-weight gain to 0.017. We reimplemented a published method, VAECox, which showed no pretraining gain over random initialisation at the last or validation-selected training step. Choosing each network's best test step, as the published code does, raised concordance by 0.03 to 0.05 across the 13-cancer and ten-cancer overall-survival settings, but barely changed the difference between networks. In a constructed post hoc experiment, choosing the best test step only for the pretrained network changed the equal-weight mean difference from -0.004 to +0.045 (+0.035 to +0.054). Across seven multi-omics comparisons, estimates from single five-fold runs differed from their cancer's five-run mean by at least 0.02 in 11% to 42% of runs. Concordance was about 0.02 lower at held-out tissue source sites. Interpreting a reported gain therefore requires each model's selection rule, variation across repeated partitions, the weighting of cancers and the evaluation population.

bioinformatics↗